Table 2. Grade 2+ Pulmonary Adverse Events within 12 months.
Observation<br>(n=13) | Captopril<br>(n=7) | |||
---|---|---|---|---|
Follow-up Time (months) | ||||
Median | 16.3 | 17.8 | ||
Range | 3.4 – 30.0 | 4.0 – 27.2 | ||
Time to Grade 2+ Pulmonary adverse event(Radiation) | ||||
Median | 2.93 | 3.29 | ||
Range | 1.9 – 7.9 | 3.29 – 3.29 | ||
Time to Grade 2+ Pulmonary adverse event(Any modality) | ||||
Median | 2.73 | 4.77 | ||
Range | 1.9 – 7.9 | 3.3 – 6.7 | ||
Events | % | Events | % | |
|
||||
Grade 2+ Pulmonary adverse event<br>(Radiation) | 3 | 23 | 1 | 14 |
Grade 2+ Pulmonary adverse event<br>(Any modality) | 5 | 39 | 4 | 57 |
CTCAE v3.0